A first-in-man, double blind, placebo controlled study of the candidate therapeutic vaccine Opal-HIV-Gag(c) in HIV infected patients receiving HAART

Detalles Bibliográficos
Autores principales: Jackson, AG, Kløverpris, HN, Handley, A, Hayes, P, Gilmour, J, Atkins, M, Walker, B, Ackland, J, Sullivan, M, Goulder, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Oral Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441710/
http://dx.doi.org/10.1186/1742-4690-9-S2-O54

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441710/
http://dx.doi.org/10.1186/1742-4690-9-S2-O54

Ejemplares similares